#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ureteric cancer Ovarian cancer stage IV Chronic myeloid leukaemia Metastatic malignant melanoma Cryoglobulinaemia Ocular lymphoma Adrenoleukodystrophy Parkinson's disease Leiomyosarcoma recurrent Trigeminal neuralgia Hepatitis B Hepatic angiosarcoma Factor IX deficiency Biliary neoplasm Oesophageal adenocarcinoma More trials…

    Learn about Rare Diseases

    Haemophilia Hairy cell leukaemia – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Diagnostics Vascular malformation – Basic Information Mantle cell lymphoma – Diagnostics Mucopolysaccharidosis – Trials in Disease Hypereosinophilic syndrome – Trials in Disease Bronchopulmonary dysplasia – Diagnostics Piriformis syndrome Acquired haemophilia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Flutemetamol (18F) FRUQUINTINIB Hu5F9‐G4 Rhh646 Pralsetinib Asciminib Vb10.16 Ly3298176 Calcium Pantothenate Bp Rasagiline Alternaria Alternata Extract Gefurulimab HUMAN FIBROBLASTS Triptorelin Pamoate Sorafenib Ublituximab Selexipag Ulipristal Acetate Rilpivirine Co-Trimoxazole More therapies…

    Learn about Your Condition

    Medication overuse headache Hot flush Glomerulonephritis acute Pharyngeal cancer stage III Radius fracture Pulmonary embolism Anaemia of chronic disease Papillary thyroid cancer Burning mouth syndrome Renal disorder Dermatomyositis Glomerulonephritis Vaginal infection Vesicoureteric reflux Kaposi's sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Usher’s syndrome

  • Study on Long-Term Safety and Effects of SAR421869 for Patients with Usher Syndrome Type 1B

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Usher’s syndrome
    Investigated Drugs:
    • Lentiviral Vector Derived From The Equine Infectious Anaemia Virus Containing The Human Myo7A Gene
    France

  • Study of AAVB-081 and Prednisolone for Patients with Usher Syndrome Type 1B Retinitis Pigmentosa

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Usher’s syndrome
    • Retinitis pigmentosa
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 8 Containing The 3′-Myo7A Gene Coding Sequence
    • Adeno-Associated Viral Vector Serotype 8 Containing The 5′-Myo7A Gene Coding Sequence
    • Prednisolone
    Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!